Open Journal of Ophthalmology

Volume 6, Issue 1 (February 2016)

ISSN Print: 2165-7408   ISSN Online: 2165-7416

Google-based Impact Factor: 0.27  Citations  

Novel Mechanistic Interplay between Products of Oxidative Stress and Components of the Complement System in AMD Pathogenesis

HTML  XML Download Download as PDF (Size: 519KB)  PP. 43-50  
DOI: 10.4236/ojoph.2016.61006    3,160 Downloads   3,933 Views  Citations

ABSTRACT

Age-related macular degeneration (AMD) is a leading cause of vision loss affecting tens of millions of elderly worldwide. Early AMD includes soft drusen and pigmentary changes in the retinal pigment epithelium (RPE). As people age, such soft confluent drusen can progress into two forms of advanced AMD, geographic atrophy (GA, or dry AMD) or choroidal neovascularization (CNV, or wet AMD) and result in the loss of central vision. The exact mechanism for developing early AMD and progressing to advanced stage of disease is still largely unknown. However, significant evidence exists demonstrating a complex interplay of genetic and environmental factors as the cause of AMD progression. Together, complement factor H (CFH) and HTRA1/ARMS polymorphisms contribute to more than 50% of the genetic risk for AMD. Environmentally, oxidative stress from activities such as smoking has also demonstrated a powerful contribution to AMD progression. To extend our previous finding that genetic polymorphisms in CFH results in OxPLs and the risk-form of CFH (CFH Y402H) has reduced affinity for oxidized phospholipids, and subsequent diminished capacity which subsequently diminishes the capability to attenuate the inflammatory effects of these molecules, we compared the binding properties of CFH and CFH related protein 1 (CFHR1), which is also associated with disease risk, to OxPLs and their effects on modulating inflammation and lipids uptake. As both CFH-402H and CFHR1 are associated with increased risk to AMD, we hypothesized that like CFH-402H, CFHR1 contribution to AMD risk may also be due to its diminished affinity for OxPLs. Interestingly, we found that association of CFHR1 with OxPLs was not statistically different than CFH. However, binding of CFHR1 did not elicit the same protective benefits as CFH in that both inflammation and lipid uptake are unaffected by CFHR1 association with OxPLs. These findings demonstrate a novel and interesting complexity to the potential interplay between the complement system and oxidative stress byproducts, such as OxPLs, in the mechanistic contribution to AMD. Future work will aim to identify the molecular distinctions between CFH and CFHR1 which confer protection by the former, but not latter molecules. Understanding the molecular domains necessary for protection could provide interventional insights in the generation of novel therapeutics for AMD and other diseases associated with oxidative stress.

Share and Cite:

Du, H. , Xiao, X. , Stiles, T. , Douglas, C. , Ho, D. and Shaw, P. (2016) Novel Mechanistic Interplay between Products of Oxidative Stress and Components of the Complement System in AMD Pathogenesis. Open Journal of Ophthalmology, 6, 43-50. doi: 10.4236/ojoph.2016.61006.

Cited by

[1] The complement system in age-related macular degeneration
2021
[2] Interlink between Inflammation and Oxidative Stress in Age-Related Macular Degeneration: Role of Complement Factor H
2021
[3] Protective Effect of a Bispecific Fc-Fusion Protein on the Barrier of Human Retinal Pigment Epithelial Cells
2021
[4] SIRT1 relieves Necrotizing Enterocolitis through inactivation of Hypoxia-inducible factor (HIF)-1a
Cell Cycle, 2020
[5] ИЗМЕНЕНИЯ ИММУННОГО И АНТИОКСИДАНТНОГО СТАТУСА И РОЛЬ ВИТАМИНА D В ИХ КОРРЕКЦИИ У ПЕДАГОГОВ ПОЖИЛОГО ВОЗРАСТА
2020
[6] OxLDL enhances choroidal neovascularization lesion through inducing vascular endothelium to mesenchymal transition process and angiogenic factor expression
2020
[7] A modified laser-induced choroidal neovascularization animal model with intravitreal oxidized low-density lipoprotein
2020
[8] Vergleichende Evaluation der Lebensqualität von mit Lucentis® behandelten Patienten mit diabetischer Retinopathie und altersbedingter Makuladegeneration
2020
[9] Коррекция оксидативного стресса в лечении тяжелых форм сухого кератоконъюнктивита при синдроме Шегрена
2019
[10] Autophagy Dysfunction, Cellular Senescence, and Abnormal Immune-Inflammatory Responses in AMD: From Mechanisms to Therapeutic Potential
2019
[11] Pharmacodynamic Evaluation: Ocular Pharmacology
2019
[12] Autophagy and Age-Related Eye Diseases
2019
[13] Diacron reactive oxygen metabolites and biological antioxidant potential tests for patients with age-related macular degeneration
2019
[14] CFH and HTRA1 Exhibit Antagonistic Effect on Inhibiting Oxidized Phospholipids Uptake in Human Retinal Pigment Epithelial Cells
2019
[15] IL-10 inhibits retinal pigment epithelium cell proliferation and migration through regulation of VEGF in rhegmatogenous retinal detachment
2018
[16] АНТИОКСИДАНТНАЯ РОЛЬ МЕЛАТОНИНА И ЭРИТРОПОЭТИНА ПРИ ОКИСЛИТЕЛЬНОМ СТРЕССЕ
2018
[17] ВЛИЯНИЕ МЕЛАТОНИНА НА КИСЛОРОДСВЯЗЫВАЮЩИЕ СВОЙСТВА КРОВИ ПРИ ОКИСЛИТЕЛЬНОМ СТРЕССЕ
2017
[18] Nutritional Supplementation Inhibits the Increase in Serum Malondialdehyde in Patients with Wet Age-Related Macular Degeneration
Oxidative Medicine and Cellular Longevity, 2017
[19] Salvianolic Acid A Inhibits OX-LDL Effects on Exacerbating Choroidal Neovascularization via Down-regulating CYLD
Oxidative Medicine and Cellular Longevity, 2017
[20] Nutritional Supplementation Inhibits the Increase in Serum Malondialdehyde in 1 Patients with Wet Age-related Macular Degeneration 2
Oxidative Medicine and Cellular Longevity, 2017
[21] Inhibition of osteoarthritis chondrocyte proliferation by IL-10 via modulating NF-κB and related mechanisms
2017
[22] Salvianolic Acid A Inhibits OX-LDL Effects on Exacerbating Choroidal Neovascularization via Downregulating CYLD
Oxidative Medicine and Cellular Longevity, 2017
[23] Участие мелатонина в регуляции кислородтранспортной функции крови при окислительном стрессе, вызванном введением липополисахарида
2017
[24] The Visual Impairment/Cognitive Impairment Co-morbidity: Examining the Genotype-Structure-Function Relationship
2017
[25] ВОЗРАСТНАЯ МАКУЛЯРНАЯ ДЕГЕНЕРАЦИЯ: ОСОБЕННОСТИ МОРФОГЕНЕЗА И КЛИНИЧЕСКОГО ТЕЧЕНИЯ

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.